- Home
- GSK vs MFG Comparison
GSK vs MFG Comparison
Compare GSK & MFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- MFG
- Stock Information
- Founded
- GSK 1715
- MFG 2003
- Country
- GSK United Kingdom
- MFG Japan
- Employees
- GSK N/A
- MFG N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- MFG Major Banks
- Sector
- GSK Health Care
- MFG Finance
- Exchange
- GSK Nasdaq
- MFG Nasdaq
- Market Cap
- GSK 68.2B
- MFG 65.3B
- IPO Year
- GSK N/A
- MFG 2000
- Fundamental
- Price
- GSK $33.78
- MFG $5.19
- Analyst Decision
- GSK Hold
- MFG
- Analyst Count
- GSK 5
- MFG 0
- Target Price
- GSK $45.50
- MFG N/A
- AVG Volume (30 Days)
- GSK 3.5M
- MFG 1.1M
- Earning Date
- GSK 02-05-2025
- MFG 01-31-2025
- Dividend Yield
- GSK 4.62%
- MFG 1.35%
- EPS Growth
- GSK N/A
- MFG 30.13
- EPS
- GSK 0.81
- MFG 2.28
- Revenue
- GSK $41,966,224,352.00
- MFG $25,014,848,091.00
- Revenue This Year
- GSK $5.80
- MFG N/A
- Revenue Next Year
- GSK $3.69
- MFG $6.11
- P/E Ratio
- GSK $20.19
- MFG $11.08
- Revenue Growth
- GSK 5.59
- MFG 12.06
- 52 Week Low
- GSK $31.72
- MFG $3.45
- 52 Week High
- GSK $45.93
- MFG $5.31
- Technical
- Relative Strength Index (RSI)
- GSK 50.09
- MFG 61.68
- Support Level
- GSK $31.72
- MFG $5.04
- Resistance Level
- GSK $34.46
- MFG $5.18
- Average True Range (ATR)
- GSK 0.47
- MFG 0.07
- MACD
- GSK 0.06
- MFG 0.02
- Stochastic Oscillator
- GSK 75.00
- MFG 96.05
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About MFG Mizuho Financial Group Inc. Sponosred ADR (Japan)
Mizuho Financial Group is roughly tied with megabank peer Sumitomo Mitsui Financial Group for the status as Japan's second-largest bank after Mitsubishi UFJ Financial Group. As of March 2024, Mizuho's market share of domestic loans was 6.8%, compared with 7.2% for SMFG and 8.0% for MUFG. In Japan, Mizuho has more of a corporate focus than SMFG, which has a larger retail business. Its overseas weighting is slightly smaller than that of MUFG. Unlike its two Japanese megabank peers that own foreign banks outright or hold noncontrolling stakes in local banks overseas, Mizuho expanded in recent years beyond its traditional Japanese borrowers, mainly through its core banking and securities units, focusing on the financing needs of global multinational corporations.